X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1336) 1336
Publication (83) 83
Book Review (9) 9
Newsletter (5) 5
Magazine Article (3) 3
Data Set (1) 1
Dissertation (1) 1
Newspaper Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1225) 1225
idarubicin - administration & dosage (892) 892
male (833) 833
female (819) 819
middle aged (739) 739
antineoplastic combined chemotherapy protocols - therapeutic use (734) 734
adult (680) 680
cytarabine - administration & dosage (640) 640
hematology (610) 610
oncology (569) 569
aged (519) 519
idarubicin (497) 497
remission induction (394) 394
leukemia, myeloid, acute - drug therapy (367) 367
index medicus (340) 340
chemotherapy (336) 336
adolescent (332) 332
treatment outcome (323) 323
antineoplastic combined chemotherapy protocols - adverse effects (257) 257
acute myelogenous leukemia (237) 237
antineoplastic combined chemotherapy protocols - administration & dosage (237) 237
idarubicin - adverse effects (234) 234
etoposide - administration & dosage (227) 227
daunorubicin - administration & dosage (208) 208
cancer (196) 196
disease-free survival (191) 191
acute disease (178) 178
acute myeloid-leukemia (177) 177
therapy (177) 177
acute myeloid leukemia (167) 167
idarubicin - therapeutic use (160) 160
cytarabine (150) 150
anthracyclines (148) 148
leukemia (144) 144
leukemia, myeloid - drug therapy (144) 144
leukemia, promyelocytic, acute - drug therapy (143) 143
recurrence (140) 140
aged, 80 and over (139) 139
prognosis (139) 139
survival rate (138) 138
daunorubicin (137) 137
survival analysis (136) 136
administration, oral (130) 130
child (129) 129
cytarabine - adverse effects (124) 124
tretinoin - administration & dosage (124) 124
drug administration schedule (121) 121
antibiotics, antineoplastic - administration & dosage (120) 120
combined modality therapy (120) 120
cytosine-arabinoside (120) 120
leukemia, myeloid, acute - mortality (120) 120
mitoxantrone - administration & dosage (112) 112
dose-response relationship, drug (105) 105
vidarabine - analogs & derivatives (103) 103
child, preschool (102) 102
daunorubicin - analogs & derivatives (98) 98
young adult (98) 98
aml (96) 96
pharmacology & pharmacy (91) 91
vidarabine - administration & dosage (91) 91
retrospective studies (88) 88
animals (85) 85
cyclophosphamide - administration & dosage (85) 85
acute promyelocytic leukemia (84) 84
follow-up studies (83) 83
antineoplastic agents - therapeutic use (82) 82
adult patients (81) 81
doxorubicin (79) 79
medicine & public health (78) 78
transplantation (78) 78
hematopoietic stem cell transplantation (74) 74
antineoplastic agents - administration & dosage (73) 73
precursor cell lymphoblastic leukemia-lymphoma - drug therapy (73) 73
survival (72) 72
granulocyte colony-stimulating factor - administration & dosage (71) 71
leukemia, myeloid, acute - pathology (71) 71
trial comparing idarubicin (71) 71
drug evaluation (70) 70
risk factors (70) 70
antibiotics, antineoplastic - adverse effects (68) 68
colony-stimulating factor (68) 68
idarubicin - pharmacokinetics (68) 68
infant (68) 68
time factors (68) 68
antibiotics, antineoplastic - therapeutic use (66) 66
trial (66) 66
bone marrow transplantation (65) 65
relapse (65) 65
vincristine - administration & dosage (65) 65
acute nonlymphocytic leukemia (64) 64
daunorubicin - therapeutic use (64) 64
remission (63) 63
daunorubicin - adverse effects (62) 62
leukemia, myeloid, acute - genetics (62) 62
leukemia, myeloid, acute - therapy (62) 62
leukemia, myeloid - mortality (61) 61
prospective studies (60) 60
salvage therapy (60) 60
bone-marrow transplantation (59) 59
dexamethasone - administration & dosage (58) 58
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1275) 1275
Japanese (30) 30
Chinese (14) 14
German (8) 8
Spanish (5) 5
Hungarian (4) 4
Russian (4) 4
French (3) 3
Polish (2) 2
Czech (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2010, Volume 376, Issue 9757, pp. 2009 - 2017
Summary Background Although survival of children with acute lymphoblastic leukaemia has improved greatly in the past two decades, the outcome of those who... 
Internal Medicine | MEDICINE, GENERAL & INTERNAL | IDARUBICIN | THERAPY | DOSE ARA-C | PEDIATRIC-PATIENTS | SENSITIVITY | RISK | CHILDHOOD LEUKEMIA | EXPERIENCE | ACCELERATED APPROVAL | ONCOLOGY GROUP | Recurrence | Cyclophosphamide - administration & dosage | Humans | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Child, Preschool | Infant | Male | Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy | Vincristine - administration & dosage | Female | Leukocyte Count | Child | Idarubicin - therapeutic use | Mitoxantrone - therapeutic use | Dexamethasone - administration & dosage | Risk Assessment | Kaplan-Meier Estimate | Mercaptopurine - administration & dosage | Etoposide - administration & dosage | Treatment Outcome | United Kingdom | Vidarabine - analogs & derivatives | Cytarabine - administration & dosage | Polyethylene Glycols - administration & dosage | Asparaginase - administration & dosage | Disease-Free Survival | Antibiotics, Antineoplastic - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Adolescent | Methotrexate - administration & dosage | Vidarabine - administration & dosage | Complications and side effects | Dosage and administration | Acute lymphocytic leukemia | Drug therapy | Patient outcomes | Mitoxantrone hydrochloride | Studies | Design | Medical research | Chemotherapy | Cytogenetics | Cancer therapies | Data bases | Cancer | Ovarian cancer
Journal Article
Blood, ISSN 0006-4971, 10/2010, Volume 116, Issue 17, pp. 3171 - 3179
Journal Article
Blood, ISSN 0006-4971, 08/2012, Volume 120, Issue 8, pp. 1570 - 1580
Journal Article
Blood, ISSN 0006-4971, 12/2003, Volume 102, Issue 13, pp. 4277 - 4283
Journal Article
Pediatric Blood & Cancer, ISSN 1545-5009, 04/2008, Volume 50, Issue 4, pp. 739 - 745
Purpose We prospectively studied the efficacy of high dose therapy (HDT) versus an oral maintenance treatment (OMT) in patients with stage IV soft tissue... 
myeloablative therapy | rhabdomyosarcoma | soft tissue sarcoma | bone rhabdomyosarcoma | Soft tissue sarcoma | Bone rhabdomyosarcoma | Rhabdomyosarcoma | Myeloablative therapy | PROGNOSTIC-FACTORS | SOLID TUMORS | TROFOSFAMIDE | NEUROBLASTOMA | rnyeloablative therapy | CHILDHOOD | RESCUE | ONCOLOGY | ADOLESCENTS | PEDIATRICS | INTERGROUP | STEM-CELL TRANSPLANTATION | HEMATOLOGY | Cyclophosphamide - administration & dosage | Cyclophosphamide - analogs & derivatives | Soft Tissue Neoplasms - mortality | Thiotepa - administration & dosage | Humans | Kaplan-Meier Estimate | Carboplatin - administration & dosage | Child, Preschool | Soft Tissue Neoplasms - drug therapy | Etoposide - administration & dosage | Infant | Male | Treatment Outcome | Dactinomycin - administration & dosage | Epirubicin - administration & dosage | Sarcoma - drug therapy | Melphalan - administration & dosage | Ifosfamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Sarcoma - mortality | Vincristine - administration & dosage | Female | Idarubicin - administration & dosage | Child | Index Medicus | Pediatrics | Pediatrik | Immunologi inom det medicinska området | administration & dosage | Melphalan | Epirubicin | Immunology in the medical area | drug therapy | Sarcoma | Ifosfamide | Antineoplastic Combined Chemotherapy Protocols | Preschool | Etoposide | Dactinomycin | Vincristine | Cyclophosphamide | analogs & derivatives | Soft Tissue Neoplasms | Thiotepa | Carboplatin | mortality | Idarubicin | therapeutic use | Kaplan-Meiers Estimate
Journal Article
Journal Article
Blood, ISSN 0006-4971, 06/2014, Volume 123, Issue 26, pp. 4027 - 4036
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 06/2011, Volume 29, Issue 18, pp. e534 - e536
Journal Article
American Journal of Hematology, ISSN 0361-8609, 11/2013, Volume 88, Issue 11, pp. 961 - 966
Clofarabine is a second generation nucleoside analogue with activity in adults with acute myeloid leukemia (AML). A phase I trial of clofarabine, idarubicin,... 
PHASE-III TRIAL | SOUTHWEST-ONCOLOGY-GROUP | DOSE CYTOSINE-ARABINOSIDE | GROUP-B | ARA-C | DAUNORUBICIN | HEMATOLOGY | CANCER | CHEMOTHERAPY | MODULATION | INDUCTION TREATMENT | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Age Factors | Follow-Up Studies | Nausea - chemically induced | Cytarabine - therapeutic use | Humans | Middle Aged | Antibiotics, Antineoplastic - adverse effects | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Cytarabine - adverse effects | Antimetabolites, Antineoplastic - administration & dosage | Young Adult | Arabinonucleosides - administration & dosage | Idarubicin - adverse effects | Leukemia, Myeloid, Acute - drug therapy | Adult | Idarubicin - administration & dosage | Adenine Nucleotides - administration & dosage | Idarubicin - therapeutic use | Drug Eruptions - etiology | Adenine Nucleotides - therapeutic use | Arabinonucleosides - adverse effects | Remission Induction | Arabinonucleosides - therapeutic use | Cytarabine - administration & dosage | Adenine Nucleotides - adverse effects | Induction Chemotherapy - adverse effects | Antibiotics, Antineoplastic - administration & dosage | Antimetabolites, Antineoplastic - therapeutic use | Pilot Projects | Antibiotics, Antineoplastic - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Antimetabolites, Antineoplastic - adverse effects | Survival Analysis | Consolidation Chemotherapy - adverse effects | Anthracyclines | Index Medicus | AML | idarubicin | cytarabine | frontline therapy | clofarabine
Journal Article
Hematological Oncology, ISSN 0278-0232, 03/2014, Volume 32, Issue 1, pp. 52 - 55
DIAGNOSED MULTIPLE-MYELOMA | PLUS DEXAMETHASONE | ONCOLOGY | CYCLOPHOSPHAMIDE | STEM-CELL TRANSPLANTATION | INTERLEUKIN-6 | HEMATOLOGY | Pregnancy Complications, Neoplastic - diagnosis | Cyclophosphamide - administration & dosage | Humans | Pyrazines - administration & dosage | Plasmacytoma - genetics | Male | Osteolysis - etiology | Transplantation, Autologous | Postpartum Period | Osteolysis - diagnosis | Chemoradiotherapy | Cisplatin - administration & dosage | Contraindications | Thalidomide - analogs & derivatives | Multiple Myeloma - drug therapy | Fatal Outcome | Pregnancy Complications, Neoplastic - drug therapy | Adult | Female | Idarubicin - administration & dosage | Boronic Acids - administration & dosage | Thoracic Vertebrae - pathology | Infant, Newborn | Doxorubicin - administration & dosage | Bortezomib | Dexamethasone - administration & dosage | Multiple Myeloma - diagnosis | Hematopoietic Stem Cell Transplantation | Myeloma Proteins - analysis | Etoposide - administration & dosage | Combined Modality Therapy | Spinal Cord Compression - etiology | Thalidomide - administration & dosage | Remission Induction | Cytarabine - administration & dosage | Pregnancy Complications, Neoplastic - urine | Plasmacytoma - diagnosis | Pregnancy | Cesarean Section | Dexamethasone - therapeutic use | Melphalan - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Hypercalcemia - etiology | Plasmacytoma - therapy | Pregnancy Complications, Neoplastic - therapy | Pregnancy Outcome | Methylprednisolone - administration & dosage | Pregnant women
Journal Article
British Journal of Haematology, ISSN 0007-1048, 09/2016, Volume 174, Issue 5, pp. 700 - 710
Journal Article
Journal Article